Candel Therapeutics, Inc.

Q1 2024 13F Holders

Symbol
CADL
CUSIP
137404109
Type
Equity
Class
COM
Num filings
22
Total reported value, excl. options
$5.97 M
Manager Report Date Value ($000) Shares Option Type